Periodontal pockets: A potential reservoir for SARS-CoV-2?

被引:76
|
作者
Badran, Zahi [1 ,2 ]
Gaudin, Alexis [3 ]
Struillou, Xavier [1 ]
Amador, Gilles [4 ]
Soueidan, Assem [1 ]
机构
[1] Univ Nantes, CHU Nantes, Dept Periodontol Rmes U1229, UIC 11,Fac Dent Surg, Nantes, France
[2] McGill Univ, Fac Dent, Montreal, PQ, Canada
[3] Univ Nantes, CHU Nantes, Dept Endodont Rmes U1229, UIC 11,Fac Dent Surg, Nantes, France
[4] Univ Nantes, CHU Nantes, Dept Dent Publ Hlth UPRES EA 3826, UIC 11,Fac Dent Surg, Nantes, France
关键词
VIRUSES; INFECTION; CELLS; HEALTHY; DISEASE;
D O I
10.1016/j.mehy.2020.109907
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Periodontal pockets are the major clinical manifestation of Periodontitis, a chronic inflammatory oral disease affecting the teeth-supporting tissues and has high prevalence in the adult population. Periodontal pockets are ideal environments for subgingival bacterial biofilms, that interact with the supragingival oral cavity, mucosal tissues of the pocket and a peripheral circulatory system. Periodontal pockets have been found to harbor viral species such as the Herpes simplex viruses' family. Recently, the SARS-CoV-2 has gained major interest of the scientific/medical community as it caused a global pandemic (Covid-19) and paralyzed the globe with high figures of infected people worldwide. This virus behavior is still partially understood, and by analyzing some of its features we hypothesized that periodontal pocket could be a favorable anatomical niche for the virus and thus acting as a reservoir for SARS-CoV-2.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Potential threat of SARS-CoV-2 in coastal waters
    Guo, Weijun
    Cao, Yimeng
    Kong, Xiangpeng
    Kong, Shujun
    Xu, Tiaojian
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2021, 220
  • [42] Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2
    Alkotaji, Myasar
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (06)
  • [43] Unravelling the Potential of Anticancer Drugs for SARS-CoV-2
    Low, Zheng Yao
    Wong, Ka Heng
    Yip, Ashley Jia Wen
    Liew, Hern Liang
    Farouk, Isra Ahmad
    Lal, Sunil Kumar
    Choo, Wee Sim
    CURRENT PHARMACOLOGY REPORTS, 2025, 11 (01)
  • [44] Recent insights of SARS-CoV-2 potential inhibitors
    Faheem, Mohd
    Singh, Vinay Kumar
    Srivastava, Abhishek
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2022, 6 (01): : 21 - 32
  • [45] Potential zoonotic sources of SARS-CoV-2 infections
    Jo, Wendy K.
    de Oliveira-Filho, Edmilson Ferreira
    Rasche, Andrea
    Greenwood, Alex D.
    Osterrieder, Klaus
    Drexler, Jan Felix
    TRANSBOUNDARY AND EMERGING DISEASES, 2021, 68 (04) : 1824 - 1834
  • [46] Potential SARS-CoV-2 main protease inhibitors
    Banerjee, Riddhidev
    Perera, Lalith
    Tillekeratne, L. M. Viranga
    DRUG DISCOVERY TODAY, 2021, 26 (03) : 804 - 816
  • [47] Infection with SARS-CoV-2 as a potential achalasia trigger
    Zafra, Pilar Ruz
    Sanchez, Carlos Javier Garcia
    Ramirez, Alberto Perez
    Soto, Ana Guil
    Carnerero, Eduardo Leo
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2023, 115 (04) : 203 - 204
  • [48] Potential inhibitors for the novel coronavirus (SARS-CoV-2)
    Han, Yanqiang
    Wang, Zhilong
    Ren, Jiahao
    Wei, Zhiyun
    Li, Jinjin
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (02) : 1225 - 1231
  • [49] Potential complications and sequelae of SARS-CoV-2 infection
    Modi, Jyoti Nath
    Ghosh, Amrita
    Pal, Ranabir
    Mohan, Rajashekar
    Moscote-Salazar, Luis Rafael
    Wakode, Santosh
    Agrawal, Amit
    INDIAN JOURNAL OF RESPIRATORY CARE, 2021, 10 (01) : 4 - 9
  • [50] Potential Unconventional Medicines for the Treatment of SARS-CoV-2
    Coppola, Maurizio
    Mondola, Raffaella
    DRUG RESEARCH, 2020, 70 (06) : 286 - 286